Research has indicated that oral administration of melatonin can substantially decrease nitrate/nitrite levels, lower MDA levels, and enhance myeloperoxidase (MPO) content, thereby alleviating pulmonary interstitial fibrosis in neonatal rats suffering from BPD and increasing alveolar counts (Pan et al., 2009). This evidence concerns the gene MPO and bronchopulmonary dysplasia.